Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
44,565,097
-
Total 13F shares
-
41,491,947
-
Share change
-
+41,491,947
-
Total reported value
-
$434,056,422
-
Price per share
-
$10.46
-
Number of holders
-
47
-
Value change
-
+$434,056,390
-
Number of buys
-
47
Institutional Holders of Sionna Therapeutics, Inc. - Common Stock, $0.001 par value per share (SION) as of Q1 2025
As of 31 Mar 2025,
Sionna Therapeutics, Inc. - Common Stock, $0.001 par value per share (SION) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,491,947 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., TPG GP A, LLC, ORBIMED ADVISORS LLC, Atlas Venture Life Science Advisors, LLC, VIKING GLOBAL INVESTORS LP, ENAVATE SCIENCES GP, LLC, JPMORGAN CHASE & CO, PERCEPTIVE ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, and JENNISON ASSOCIATES LLC.
This page lists
47
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.